Van Wagoner DR - Search Results

1

Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation.

Lal JC, Mao C, Zhou Y, Gore-Panter SR, Rennison JH, Lovano BS, Castel L, Shin J, Gillinov AM, Smith JD, Barnard J, Van Wagoner DR, Luo Y, Cheng F, Chung MK. Lal JC, et al. Among authors: van wagoner dr. Cell Rep Med. 2022 Oct 18;3(10):100749. doi: 10.1016/j.xcrm.2022.100749. Epub 2022 Oct 11. Cell Rep Med. 2022. PMID: 36223777 Free PMC article.

2

Atrial L-type Ca2+ currents and human atrial fibrillation.

Van Wagoner DR, Pond AL, Lamorgese M, Rossie SS, McCarthy PM, Nerbonne JM. Van Wagoner DR, et al. Circ Res. 1999 Sep 3;85(5):428-36. doi: 10.1161/01.res.85.5.428. Circ Res. 1999. PMID: 10473672

3

Molecular basis of electrical remodeling in atrial fibrillation.

Van Wagoner DR, Nerbonne JM. Van Wagoner DR, et al. J Mol Cell Cardiol. 2000 Jun;32(6):1101-17. doi: 10.1006/jmcc.2000.1147. J Mol Cell Cardiol. 2000. PMID: 10888261 Review.

4

Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation.

Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S, Kanderian A, Pavia S, Hamlin RL, McCarthy PM, Bauer JA, Van Wagoner DR. Carnes CA, et al. Among authors: van wagoner dr. Circ Res. 2001 Sep 14;89(6):E32-8. doi: 10.1161/hh1801.097644. Circ Res. 2001. PMID: 11557745 Clinical Trial.

5

C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation.

Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, Van Wagoner DR. Chung MK, et al. Among authors: van wagoner dr. Circulation. 2001 Dec 11;104(24):2886-91. doi: 10.1161/hc4901.101760. Circulation. 2001. PMID: 11739301

6

Basic mechanisms of atrial fibrillation.

Van Wagoner DR. Van Wagoner DR. Cleve Clin J Med. 2003 Jul;70 Suppl 3:S2-5. doi: 10.3949/ccjm.70.suppl_3.s2. Cleve Clin J Med. 2003. PMID: 12882402 Free article. Review. No abstract available.

7

Electrophysiological remodeling in human atrial fibrillation.

Van Wagoner DR. Van Wagoner DR. Pacing Clin Electrophysiol. 2003 Jul;26(7 Pt 2):1572-5. doi: 10.1046/j.1460-9592.2003.t01-1-00234.x. Pacing Clin Electrophysiol. 2003. PMID: 12914605 Review.

8

Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes.

Fedida D, Eldstrom J, Hesketh JC, Lamorgese M, Castel L, Steele DF, Van Wagoner DR. Fedida D, et al. Among authors: van wagoner dr. Circ Res. 2003 Oct 17;93(8):744-51. doi: 10.1161/01.RES.0000096362.60730.AE. Epub 2003 Sep 18. Circ Res. 2003. PMID: 14500335

9

Inflammation as a risk factor for atrial fibrillation.

Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS, Chung MK. Aviles RJ, et al. Among authors: van wagoner dr. Circulation. 2003 Dec 16;108(24):3006-10. doi: 10.1161/01.CIR.0000103131.70301.4F. Epub 2003 Nov 17. Circulation. 2003. PMID: 14623805

10

Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo.

Tian XL, Yong SL, Wan X, Wu L, Chung MK, Tchou PJ, Rosenbaum DS, Van Wagoner DR, Kirsch GE, Wang Q. Tian XL, et al. Among authors: van wagoner dr. Cardiovasc Res. 2004 Feb 1;61(2):256-67. doi: 10.1016/j.cardiores.2003.11.007. Cardiovasc Res. 2004. PMID: 14736542 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page